Recordati

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.

Recordati’s mission is to provide high-quality medications to its patients, providing innovative and cost-effective solutions to patients’ needs.

Recordati’s vision is to be a leading global player in the pharmaceutical industry, offering innovative, safe and effective treatments, centered on the highest standards of patient care.

Recordati has won several awards over the years, including awards for innovation, corporate social responsibility and customer satisfaction. The Company has also been recognised numerous times for its contribution to the Italian economy and its commitment towards research and innovation.